Trials / Completed
CompletedNCT06199869
Cardiovascular Patients With no Standard Modifiable Risk Factors
Absence of Standard Modifiable Risk Factors Among 5000 Middle Eastern Patients With Atherosclerotic Cardiovascular Disease: Clinical Profiles and Prevalence of Other Risk Factors and Comorbidities
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,540 (actual)
- Sponsor
- Jordan Collaborating Cardiology Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
A growing number of patients develop atherosclerotic cardiovascular disease (ASCVD) despite the absence of standard modifiable risk factors (SMuRF-less). There is scarcity of studies that address this issue in the Middle Eastern population.
Detailed description
Atherosclerotic coronary artery disease (ASCAD) claims millions of lives annually on a global level and is the leading cause of death in the Middle East. There are four standard modifiable cardiovascular risk factors (SMuRFs): hypertension, type 2 diabetes mellitus, dyslipidemia, and smoking. These are very common in the Middle East and are crucial to be screened for and addressed in an affective manner. However, an increasing proportion of patients with ASCVD have none of these individual factors (SMuRF-less). Globally, this proportion comprises 11.6% of individuals with stable coronary disease and heart attack. No prior study has addressed the issue of the prevalence of SMuRF-less patients among the whole population of individuals with ASCVD in the Middle East.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Evaluation of risk factors by direct interview with subjects who have atherosclerotic cardiovascular patients | Individuals identified with a diagnosis of ASCVD will fill a one page form of the associated risk factors they have |
Timeline
- Start date
- 2024-01-22
- Primary completion
- 2025-01-01
- Completion
- 2025-01-31
- First posted
- 2024-01-10
- Last updated
- 2025-02-25
Locations
2 sites across 1 country: Jordan
Source: ClinicalTrials.gov record NCT06199869. Inclusion in this directory is not an endorsement.